Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does OLMESARTAN MEDOXOMIL Cause Haemorrhoids? 1,316 Reports in FDA Database

Lower Your Cholesterol — The Natural Way

The Oxidized Cholesterol Strategy: a science-backed plan for heart health.

See the Strategy

According to the FDA Adverse Event Reporting System (FAERS), 1,316 reports of Haemorrhoids have been filed in association with OLMESARTAN MEDOXOMIL (OLMESARTAN MEDOXOMIL). This represents 11.0% of all adverse event reports for OLMESARTAN MEDOXOMIL.

1,316
Reports of Haemorrhoids with OLMESARTAN MEDOXOMIL
11.0%
of all OLMESARTAN MEDOXOMIL reports
13
Deaths
965
Hospitalizations

How Dangerous Is Haemorrhoids From OLMESARTAN MEDOXOMIL?

Of the 1,316 reports, 13 (1.0%) resulted in death, 965 (73.3%) required hospitalization.

Is Haemorrhoids Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for OLMESARTAN MEDOXOMIL. However, 1,316 reports have been filed with the FAERS database.

What Other Side Effects Does OLMESARTAN MEDOXOMIL Cause?

Sprue-like enteropathy (3,482) Gastrooesophageal reflux disease (1,819) Acute kidney injury (1,587) Weight decreased (1,569) Diarrhoea (1,300) Hiatus hernia (938) Dizziness (885) Large intestine polyp (839) Constipation (796) Hypotension (794)

What Other Drugs Cause Haemorrhoids?

ADALIMUMAB (1,028) HYDROCHLOROTHIAZIDE\OLMESARTAN MEDOXOMIL (965) VEDOLIZUMAB (580) APIXABAN (291) INFLIXIMAB (280) METHOTREXATE (279) LENALIDOMIDE (260) RIVAROXABAN (240) ASPIRIN (208) INFLIXIMAB-DYYB (208)

Which OLMESARTAN MEDOXOMIL Alternatives Have Lower Haemorrhoids Risk?

OLMESARTAN MEDOXOMIL vs OLMETEC OLMESARTAN MEDOXOMIL vs OLODATEROL OLMESARTAN MEDOXOMIL vs OLODATEROL\TIOTROPIUM OLMESARTAN MEDOXOMIL vs OLOPATADINE OLMESARTAN MEDOXOMIL vs OLUTASIDENIB

Related Pages

OLMESARTAN MEDOXOMIL Full Profile All Haemorrhoids Reports All Drugs Causing Haemorrhoids OLMESARTAN MEDOXOMIL Demographics